Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public markets pitfalls.

Today, we focus on Canntab Therapeutics (PILL.C), a Canadian firm with patented IP for created hard-pressed cannabis distillate pills with controlled delivery, accurate dosages and superior bio-availability for medical use.

Enjoy!